市場調查報告書
商品編碼
1086990

微創成像:市場預測(2022-2027)

Minimally Invasive Imaging Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2020年全球微創影像市場規模將達到413.25億美元,預測期內復合年增長率為4.56%,預計到2027年將達到564.64億美元。

在這個市場中,醫療器械領域的技術進步正在提高效率、縮短疾病檢測時間、改進診斷過程、提高患者監測效率以及嚴格的高壓滅菌器規定。由於微創需求增加等因素,它正在蓬勃發展醫學成像系統和越來越多的慢性病病例。此外,公共和私營公司對醫療保健行業的投資增加,以及採取早期措施預防疾病作為邁向預防醫學的一步的趨勢也在推動市場發展。

本報告對全球微創成像市場進行了調查,包括市場規模和預測、市場驅動因素和挑戰、市場趨勢、按系統/最終用戶/地區、競爭形勢和主要公司的市場分析。提供概況等系統信息的。

目錄

第一章介紹

  • 市場定義
  • 市場細分

第二章調查方法

  • 調查數據
  • 先決條件

第 3 章執行摘要

  • 調查重點

第四章市場動態

  • 市場促進因素
  • 市場製約因素
  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代威脅
    • 新進入者的威脅
    • 競爭對手之間的敵對關係
  • 產業價值鏈分析

第 5 章全球微創成像市場:按系統

  • 簡介
  • 器官保存液
  • 移植診斷
  • 組織產品
  • 其他

第 6 章全球微創成像市場:按最終用戶分類

  • 簡介
  • 醫院
  • 診斷中心
  • 其他

第 7 章全球微創成像市場:按地區劃分

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 其他
  • 中東/非洲
    • 沙特阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 印度尼西亞
    • 泰國
    • 台灣
    • 其他

第8章競爭環境與分析

  • 主要公司及戰略分析
  • 初創企業和市場盈利能力
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第 9 章公司簡介

  • Hitachi Medical Systems
  • GE Healthcare
  • Boston Scientific Corporation
  • Medtronic plc
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Carestream Health
  • Trivitron Healthcare
  • FUJIFILM Corporation.
  • B. Braun Melsungen AG
  • Siemens Healthineers
目錄
Product Code: KSI061612928

The global minimally invasive imaging market is projected to grow at a CAGR of 4.56% during the forecast period to reach US$56.464 billion by 2027, from US$41.325 billion in 2020.

The global minimally invasive imaging market is thriving on the back of technological advancements in the field of medical devices, which are resulting in greater efficiency, faster disease detection times, improved diagnostic processes, and greater productivity in patient monitoring, combined with factors such as strict autoclaving regulations, the growing demand for minimally invasive medical imaging systems, and increasing cases of chronic disorders. Furthermore, rising investments in the healthcare industry by both public and private entities, as well as an increasing trend to take early action for disease prevention as a step toward preventive healthcare, will propel the market.

The market is boosted by the growing prevalence of chronic diseases and the increasing geriatric population. With age, the chance of getting illnesses rises correspondingly. Nearly 80% of the elderly in the US have at least one chronic illness, according to the Centers for Disease Control and Prevention. Furthermore, the American Medical Association predicts that by 2030, at least 60% of people aged 65 and up will have more than one chronic illness. According to the National Brain Tumor Society, 700,000 persons in the United States will be living with a brain tumor in 2020, with an additional 87,000 projected to be diagnosed. The prevalence of age-related disorders such as Alzheimer's disease, arthritis, Parkinson's disease, dementia, cancer, as well as cardiovascular diseases is predicted to rise as the worldwide geriatric population grows. The demand for new treatment choices, better healthcare facilities, and drugs will rise as the population ages.

The high cost of minimally invasive imaging systems, scarcity of skilled technicians, and strict government policies for complicated testing regimes are major factors limiting the market for minimally invasive imaging systems. Furthermore, due to certain technical restrictions associated with solitary imaging modalities, researchers are hesitant to purchase them, limiting their market expansion. For instance, CT has poor soft-tissue contrast; therefore, it provides less information on functional qualities and exposes doctors and patients to radiation.

Key Developments

Siemens Healthineers released the Acuson Redwood ultrasound system in October 2019, providing an imaging solution for clinical departments such as radiology, cardiology, and gynecology. The introduction of Al-enabled equipment is expected to boost demand, resulting in market expansion. Allengers unveiled the first domestically produced 32 slice CT scanner in India in January 2020 with the help of Canon Medical Systems. Samsung NeuroLogica increased manufacturing of their 32-slice CT scanner, mobile BodyTom, in February 2020.

By system, the global minimally invasive imaging market can be segmented into ultrasound, CT, X-ray, MRI, and others. The X-ray sector is expected to dominate the global minimally invasive imaging industry owing to the increasing use of direct radiography. The ultrasound segment is also expected to grow in the projected period.

By end-users, the global minimally invasive imaging market can be segmented into diagnostic centers, hospitals, and others, including specialty clinics and research centers. The hospital segment is expected to account for the most significant proportion. Owing to the increased demand for medical imaging modalities such as MRI systems and CT scanners in hospital settings for precise diagnosis during procedures will help propel the market forward. Furthermore, hospitals are well-equipped with medical imaging technology and competent healthcare experts to correctly treat and diagnose the bodily parts of patients.

By geography, the global minimally invasive imaging market can be segmented into the Asia Pacific, North America, the Middle East and Africa, South America, and Europe. Over the projected period, North America is expected to have a significant market share due to improved healthcare infrastructure and higher R&D investment in the healthcare industry, as well as the U.S. government's rising measures to update the healthcare system. The Asia Pacific region is expected to grow rapidly due to developing medical tourism in Asia Pacific countries such as India and the growing geriatric population in the region.

COVID-19 Insights

During the epidemic, demand for MRI and molecular imaging equipment has decreased. During the first quarter of 2020, key companies such as GE, Philips, and Siemens saw a decrease in demand for these modalities. New recommendations advised by radiology departments to decrease cross-sectional imaging, interventional radiology, and ultrasound to prevent COVID-19 transmission to staff and patients due to the COVID-19 pandemic are another factor influencing the market. However, because of multiple studies demonstrating the clinical efficacy of X-rays in diagnosing COVID-19 patients through chest scans, digital X-rays and CTs are in extremely high demand. Market companies have increased production of these modalities in response to rising demand, attempting to close the supply-demand imbalance. For instance, according to Koninklijke Philips N.V.'s Q1 results during the outbreak, the business saw an increase in demand for x-ray and CT equipment. The firm increased its medical imaging equipment output.

Market Segmentation:

  • By System

Organ preservation solutions

Transplant diagnostics

Tissue products

Others

  • By End-Users

Hospitals

Diagnostic Centers

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

iddle East and Africa

  • Saudi Arabia
  • Israel
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Powers of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. Threat of New Entrants
    • 4.3.5. Competitive Rivalry in Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL MINIMALLY INVASIVE IMAGING MARKET, BY SYSTEM

  • 5.1. Introduction
  • 5.2. Organ Preservation Solutions
  • 5.3. Transplant Diagnostics
  • 5.4. Tissue Products
  • 5.5. Others

6. GLOBAL MINIMALLY INVASIVE IMAGING MARKET, BY END-USERS 

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Diagnostic Centers
  • 6.4. Others

7. GLOBAL MINIMALLY INVASIVE IMAGING MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom 
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Taiwan 
    • 7.6.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisition, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES 

  • 9.1. Hitachi Medical Systems
  • 9.2. GE Healthcare
  • 9.3. Boston Scientific Corporation
  • 9.4. Medtronic plc
  • 9.5. Koninklijke Philips N.V.
  • 9.6. Canon Medical Systems Corporation
  • 9.7. Carestream Health
  • 9.8. Trivitron Healthcare
  • 9.9. FUJIFILM Corporation.
  • 9.10. B. Braun Melsungen AG
  • 9.11. Siemens Healthineers